Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients

{ 'indexed': { 'date-parts': [[2023, 12, 23]], 'date-time': '2023-12-23T05:58:28Z', 'timestamp': 1703311108907}, 'reference-count': 56, 'publisher': 'Elsevier BV', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2022, 1, 1]], 'date-time': '2022-01-01T00:00:00Z', 'timestamp': 1640995200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 10, 29]], 'date-time': '2021-10-29T00:00:00Z', 'timestamp': 1635465600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'funder': [ { 'DOI': '10.13039/501100002383', 'name': 'King Saud University', 'doi-asserted-by': 'publisher'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.fr', 'clinicalkey.com.au', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 1]]}, 'DOI': '10.1016/j.jiph.2021.10.024', 'type': 'journal-article', 'created': {'date-parts': [[2021, 11, 3]], 'date-time': '2021-11-03T05:34:53Z', 'timestamp': 1635917693000}, 'page': '116-122', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 20, 'title': 'Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir ' 'in severe COVID-19 Patients', 'prefix': '10.1016', 'volume': '15', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-0781-6454', 'authenticated-orcid': False, 'given': 'Rania M.', 'family': 'Sarhan', 'sequence': 'first', 'affiliation': []}, {'given': 'Hadeer S.', 'family': 'Harb', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4434-6217', 'authenticated-orcid': False, 'given': 'Ahmed E.', 'family': 'Abou Warda', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mounir M.', 'family': 'Salem-Bekhit', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-6109-0885', 'authenticated-orcid': False, 'given': 'Faiyaz', 'family': 'Shakeel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sami Ali', 'family': 'Alzahrani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yasmin M.', 'family': 'Madney', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4916-4359', 'authenticated-orcid': False, 'given': 'Marian S.', 'family': 'Boshra', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.jiph.2021.10.024_bib0005', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/S0140-6736(20)30566-3', 'article-title': 'Clinical course and risk factors for mortality of adult inpatients with ' 'COVID-19 in Wuhan, China: a retrospective cohort study', 'author': 'Zhou', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': '5', 'key': '10.1016/j.jiph.2021.10.024_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '397', 'DOI': '10.1016/j.medmal.2020.05.001', 'article-title': 'Tocilizumab therapy reduced intensive care unit admissions and/or ' 'mortality in COVID-19 patients', 'volume': '50', 'author': 'Klopfenstein', 'year': '2020', 'journal-title': 'Médecine Mal Infect'}, { 'issue': '1', 'key': '10.1016/j.jiph.2021.10.024_bib0015', 'first-page': '32', 'article-title': 'Review of therapeutic agents for the treatment of COVID-19', 'volume': '5', 'author': 'Ziaie', 'year': '2020', 'journal-title': 'J Cell Mol Anesth'}, { 'issue': '3', 'key': '10.1016/j.jiph.2021.10.024_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'issue': '11', 'key': '10.1016/j.jiph.2021.10.024_bib0025', 'doi-asserted-by': 'crossref', 'first-page': '722', 'DOI': '10.1016/S1473-3099(03)00806-5', 'article-title': 'Effects of chloroquine on viral infections: an old drug against today’s ' 'diseases', 'volume': '3', 'author': 'Savarino', 'year': '2003', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '3', 'key': '10.1016/j.jiph.2021.10.024_bib0030', 'doi-asserted-by': 'crossref', 'first-page': '863', 'DOI': '10.1002/art.27289', 'article-title': 'The protective effect of antimalarial drugs on thrombovascular events ' 'in systemic lupus erythematosus', 'volume': '62', 'author': 'Jung', 'year': '2010', 'journal-title': 'Arthritis Rheum'}, { 'issue': '1', 'key': '10.1016/j.jiph.2021.10.024_bib0035', 'doi-asserted-by': 'crossref', 'first-page': '30', 'DOI': '10.1093/jac/dkaa403', 'article-title': 'Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a ' 'systematic review and meta-analysis', 'volume': '76', 'author': 'Kashour', 'year': '2021', 'journal-title': 'J Antimicrob Chemother'}, { 'issue': '8', 'key': '10.1016/j.jiph.2021.10.024_bib0040', 'doi-asserted-by': 'crossref', 'first-page': '1501', 'DOI': '10.1007/s11739-020-02505-x', 'article-title': 'The association of treatment with hydroxychloroquine and hospital ' 'mortality in COVID-19 patients', 'volume': '15', 'author': 'Ayerbe', 'year': '2020', 'journal-title': 'Intern Emerg Med'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0045', 'doi-asserted-by': 'crossref', 'DOI': '10.7326/M21-0857', 'article-title': 'Use of hydroxychloroquine, remdesivir, and dexamethasone among adults ' 'hospitalized with COVID-19 in the United States: a retrospective cohort ' 'study', 'author': 'Mehta', 'year': '2021', 'journal-title': 'Ann Intern Med'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0050', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2019.104541', 'article-title': 'Broad-spectrum antiviral remdesivir inhibits human endemic and zoonotic ' 'deltacoronaviruses with a highly divergent RNA dependent RNA polymerase', 'volume': '169', 'author': 'Brown', 'year': '2019', 'journal-title': 'Antiviral Res'}, { 'issue': '11', 'key': '10.1016/j.jiph.2021.10.024_bib0055', 'doi-asserted-by': 'crossref', 'first-page': '1041', 'DOI': '10.1001/jama.2020.16337', 'article-title': 'Efficacy of Remdesivir in COVID-19', 'volume': '324', 'author': 'McCreary', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '4', 'key': '10.1016/j.jiph.2021.10.024_bib0060', 'doi-asserted-by': 'crossref', 'first-page': 'e2187', 'DOI': '10.1002/rmv.2187', 'article-title': 'Efficacy and safety of remdesivir in hospitalized Covid-19 patients: ' 'systematic review and meta-analysis including network meta-analysis', 'volume': '31', 'author': 'Elsawah', 'year': '2021', 'journal-title': 'Rev Med Virol'}, { 'issue': '7', 'key': '10.1016/j.jiph.2021.10.024_bib0065', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamanetworkopen.2021.14741', 'article-title': 'Association of remdesivir treatment with survival and length of ' 'hospital stay among US veterans hospitalized with COVID-19', 'volume': '4', 'author': 'Ohl', 'year': '2021', 'journal-title': 'JAMA Network Open'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0070', 'article-title': 'Remdesivir therapy in patients with COVID-19: a systematic review and ' 'meta-analysis of randomized controlled trials', 'author': 'Vegivinti', 'year': '2021', 'journal-title': 'Ann Med Surg'}, { 'issue': '11', 'key': '10.1016/j.jiph.2021.10.024_bib0075', 'doi-asserted-by': 'crossref', 'first-page': '1048', 'DOI': '10.1001/jama.2020.16349', 'article-title': 'Effect of remdesivir vs standard care on clinical status at 11 days in ' 'patients with moderate COVID-19: a randomized clinical trial', 'volume': '324', 'author': 'Spinner', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '17', 'key': '10.1016/j.jiph.2021.10.024_bib0080', 'doi-asserted-by': 'crossref', 'first-page': '1865', 'DOI': '10.1007/s40265-017-0829-7', 'article-title': 'Tocilizumab: a review in rheumatoid arthritis', 'volume': '77', 'author': 'Scott', 'year': '2017', 'journal-title': 'Drugs'}, { 'issue': '21', 'key': '10.1016/j.jiph.2021.10.024_bib0085', 'doi-asserted-by': 'crossref', 'first-page': '4813', 'DOI': '10.1111/bph.15072', 'article-title': 'Current pharmacological treatments for COVID-19: what’s next?', 'volume': '177', 'author': 'Scavone', 'year': '2020', 'journal-title': 'Br J Pharmacol'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0090', 'doi-asserted-by': 'crossref', 'DOI': '10.1111/ijcp.14079', 'article-title': 'Therapeutic efficacy, mechanical ventilation, length of hospital stay, ' 'and mortality rate in severe COVID‐19 patients treated with tocilizumab', 'author': 'Sarhan', 'year': '2021', 'journal-title': 'Int J Clin Pract'}, { 'issue': '20', 'key': '10.1016/j.jiph.2021.10.024_bib0095', 'doi-asserted-by': 'crossref', 'first-page': '10970', 'DOI': '10.1073/pnas.2005615117', 'article-title': 'Effective treatment of severe COVID-19 patients with tocilizumab', 'volume': '117', 'author': 'Xu', 'year': '2020', 'journal-title': 'Proc Natl Acad Sci'}, { 'issue': '5', 'key': '10.1016/j.jiph.2021.10.024_bib0100', 'doi-asserted-by': 'crossref', 'first-page': '644', 'DOI': '10.1164/rccm.201709-1845OC', 'article-title': 'Reliability and minimal clinically important differences of FVC. ' 'Results from the scleroderma lung studies (SLS-I and SLS-II)', 'volume': '197', 'author': 'Kafaja', 'year': '2018', 'journal-title': 'Am J Respir Crit Care Med'}, { 'issue': '7821', 'key': '10.1016/j.jiph.2021.10.024_bib0105', 'doi-asserted-by': 'crossref', 'first-page': '430', 'DOI': '10.1038/s41586-020-2521-4', 'article-title': 'Factors associated with COVID-19-related death using OpenSAFELY', 'volume': '584', 'author': 'Williamson', 'year': '2020', 'journal-title': 'Nature'}, { 'issue': '3', 'key': '10.1016/j.jiph.2021.10.024_bib0110', 'first-page': '529', 'article-title': 'Pilot prospective open, single-arm multicentre study on off-label use ' 'of tocilizumab in severe patients with COVID-19', 'volume': '38', 'author': 'Sciascia', 'year': '2020', 'journal-title': 'Clin Exp Rheumatol'}, { 'issue': '1', 'key': '10.1016/j.jiph.2021.10.024_bib0115', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s12967-020-02339-3', 'article-title': 'Why tocilizumab could be an effective treatment for severe COVID-19?', 'volume': '18', 'author': 'Fu', 'year': '2020', 'journal-title': 'J Transl Med'}, { 'issue': '7', 'key': '10.1016/j.jiph.2021.10.024_bib0120', 'doi-asserted-by': 'crossref', 'first-page': '814', 'DOI': '10.1002/jmv.25801', 'article-title': 'Tocilizumab treatment in COVID‐19: a single-center experience', 'volume': '92', 'author': 'Luo', 'year': '2020', 'journal-title': 'J Med Virol'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0125', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.tmaid.2020.101738', 'article-title': 'Early treatment of COVID-19 patients with hydroxychloroquine and ' 'azithromycin: a retrospective analysis of 1061 cases in Marseille, ' 'France', 'volume': '35', 'author': 'Million', 'year': '2020', 'journal-title': 'Travel Med Infect Dis'}, { 'issue': '10223', 'key': '10.1016/j.jiph.2021.10.024_bib0130', 'doi-asserted-by': 'crossref', 'first-page': '507', 'DOI': '10.1016/S0140-6736(20)30211-7', 'article-title': 'Epidemiological and clinical characteristics of 99 cases of 2019 novel ' 'coronavirus pneumonia in Wuhan, China: a descriptive study', 'volume': '395', 'author': 'Chen', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': '16', 'key': '10.1016/j.jiph.2021.10.024_bib0135', 'doi-asserted-by': 'crossref', 'first-page': '1574', 'DOI': '10.1001/jama.2020.5394', 'article-title': 'Baseline characteristics and outcomes of 1591 patients infected with ' 'SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy', 'volume': '323', 'author': 'Grasselli', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '1', 'key': '10.1016/j.jiph.2021.10.024_bib0140', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1002/rmv.2146', 'article-title': 'Predictors of COVID‐19 severity: a literature review', 'volume': '31', 'author': 'Gallo Marin', 'year': '2021', 'journal-title': 'Rev Med Virol'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0145', 'first-page': '1', 'article-title': 'Considering how biological sex impacts immune responses and COVID-19 ' 'outcomes', 'author': 'Scully', 'year': '2020', 'journal-title': 'Nat Rev Immunol'}, { 'issue': '11', 'key': '10.1016/j.jiph.2021.10.024_bib0150', 'doi-asserted-by': 'crossref', 'first-page': '1061', 'DOI': '10.1001/jama.2020.1585', 'article-title': 'Clinical characteristics of 138 hospitalized patients with 2019 novel ' 'coronavirus–infected pneumonia in Wuhan, China', 'volume': '323', 'author': 'Wang', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '24', 'key': '10.1016/j.jiph.2021.10.024_bib0155', 'doi-asserted-by': 'crossref', 'first-page': '2327', 'DOI': '10.1056/NEJMoa2007016', 'article-title': 'Compassionate use of remdesivir for patients with severe Covid-19', 'volume': '382', 'author': 'Grein', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '24', 'key': '10.1016/j.jiph.2021.10.024_bib0160', 'doi-asserted-by': 'crossref', 'first-page': '2293', 'DOI': '10.1056/NEJMoa1910993', 'article-title': 'A randomized, controlled trial of Ebola virus disease therapeutics', 'volume': '381', 'author': 'Mulangu', 'year': '2019', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0165', 'first-page': '1', 'article-title': 'Alternative pricing models for remdesivir and other potential ' 'treatments for COVID-19', 'author': 'Whittington', 'year': '2020', 'journal-title': 'Inst Clin Econ Rev'}, { 'issue': '5', 'key': '10.1016/j.jiph.2021.10.024_bib0170', 'doi-asserted-by': 'crossref', 'first-page': '475', 'DOI': '10.1016/S2213-2600(20)30079-5', 'article-title': 'Clinical course and outcomes of critically ill patients with SARS-CoV-2 ' 'pneumonia in Wuhan, China: a single-centered, retrospective, ' 'observational study', 'volume': '8', 'author': 'Yang', 'year': '2020', 'journal-title': 'Lancet Respir Med'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0175', 'article-title': 'Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase ' 'mutation in a B-cell immunodeficient patient with protracted Covid-19', 'author': 'Martinot', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'issue': '2', 'key': '10.1016/j.jiph.2021.10.024_bib0180', 'first-page': '215', 'article-title': 'A pilot study of hydroxychloroquine in treatment of patients with ' 'moderate COVID-19', 'volume': '49', 'author': 'Chen', 'year': '2020', 'journal-title': 'Journal of Zhejiang University (Medical Science).'}, { 'issue': '4', 'key': '10.1016/j.jiph.2021.10.024_bib0185', 'first-page': '465', 'article-title': 'The shortcomings of tocilizumab in COVID-19', 'volume': '28', 'author': 'Tirupathi', 'year': '2020', 'journal-title': 'Infez Med'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0190', 'first-page': '41', 'article-title': 'What hepatologists need to know about COVID-19?', 'volume': '2', 'author': 'Yapali', 'year': '2020', 'journal-title': 'Hepatology'}, { 'issue': '5', 'key': '10.1016/j.jiph.2021.10.024_bib0195', 'doi-asserted-by': 'crossref', 'first-page': '881', 'DOI': '10.1007/s12072-020-10077-3', 'article-title': 'Liver injury in remdesivir-treated COVID-19 patients', 'volume': '14', 'author': 'Zampino', 'year': '2020', 'journal-title': 'Hepatol Int'}, { 'issue': '5', 'key': '10.1016/j.jiph.2021.10.024_bib0200', 'doi-asserted-by': 'crossref', 'first-page': '377', 'DOI': '10.3748/wjg.v27.i5.377', 'article-title': 'Liver injury in the era of COVID-19', 'volume': '27', 'author': 'Cichoż-Lach', 'year': '2021', 'journal-title': 'World J Gastroenterol'}, { 'issue': '3', 'key': '10.1016/j.jiph.2021.10.024_bib0205', 'doi-asserted-by': 'crossref', 'first-page': '1533', 'DOI': '10.1111/bcp.14459', 'article-title': 'Serious adverse events with tocilizumab: Pharmacovigilance as an aid to ' 'prioritize monitoring in COVID-19', 'volume': '87', 'author': 'Gatti', 'year': '2021', 'journal-title': 'Br J Clin Pharmacol'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0210', 'doi-asserted-by': 'crossref', 'DOI': '10.1002/jmv.25897', 'article-title': 'Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection', 'author': 'Di Giambenedetto', 'year': '2020', 'journal-title': 'J Med Virol'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0215', 'doi-asserted-by': 'crossref', 'DOI': '10.1177/1756284820959183', 'article-title': '<? covid19?> Tocilizumab and liver injury in patients with COVID-19', 'volume': '13', 'author': 'Serviddio', 'year': '2020', 'journal-title': 'Therap Adv Gastroenterol'}, { 'issue': '10', 'key': '10.1016/j.jiph.2021.10.024_bib0220', 'doi-asserted-by': 'crossref', 'first-page': '771', 'DOI': '10.1007/s13238-020-00718-6', 'article-title': 'Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with ' 'human liver ductal organoids', 'volume': '11', 'author': 'Zhao', 'year': '2020', 'journal-title': 'Protein Cell'}, { 'issue': '6', 'key': '10.1016/j.jiph.2021.10.024_bib0225', 'doi-asserted-by': 'crossref', 'first-page': '592', 'DOI': '10.1016/j.aohep.2020.08.062', 'article-title': 'SARS-CoV-2 another kind of liver aggressor, how does it do that?', 'volume': '19', 'author': 'Lozano-Sepulveda', 'year': '2020', 'journal-title': 'Ann Hepatol'}, { 'issue': '4', 'key': '10.1016/j.jiph.2021.10.024_bib0230', 'doi-asserted-by': 'crossref', 'first-page': '807', 'DOI': '10.1016/j.jhep.2020.05.002', 'article-title': 'SARS-CoV-2 infection of the liver directly contributes to hepatic ' 'impairment in patients with COVID-19', 'volume': '73', 'author': 'Wang', 'year': '2020', 'journal-title': 'J Hepatol'}, { 'key': '10.1016/j.jiph.2021.10.024_bib0235', 'doi-asserted-by': 'crossref', 'first-page': '347', 'DOI': '10.3389/fmed.2020.00347', 'article-title': 'Liver injury in critically ill and non-critically ill COVID-19 ' 'patients: a multicenter, retrospective, observational study', 'volume': '7', 'author': 'Jiang', 'year': '2020', 'journal-title': 'Front Med'}, { 'issue': '18', 'key': '10.1016/j.jiph.2021.10.024_bib0240', 'doi-asserted-by': 'crossref', 'first-page': '1708', 'DOI': '10.1056/NEJMoa2002032', 'article-title': 'Clinical characteristics of coronavirus disease 2019 in China', 'volume': '382', 'author': 'Guan', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '2', 'key': '10.1016/j.jiph.2021.10.024_bib0245', 'doi-asserted-by': 'crossref', 'first-page': 'e445', 'DOI': '10.1093/cid/ciaa954', 'article-title': 'Tocilizumab for treatment of mechanically ventilated patients with ' 'COVID-19', 'volume': '73', 'author': 'Somers', 'year': '2021', 'journal-title': 'Clin Infect Dis'}, { 'issue': '10', 'key': '10.1016/j.jiph.2021.10.024_bib0250', 'doi-asserted-by': 'crossref', 'first-page': '2736', 'DOI': '10.1093/cid/ciaa524', 'article-title': 'Coronavirus disease 2019, superinfections, and antimicrobial ' 'development: what can we expect?', 'volume': '71', 'author': 'Clancy', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'issue': '6', 'key': '10.1016/j.jiph.2021.10.024_bib0255', 'doi-asserted-by': 'crossref', 'DOI': '10.1161/JAHA.120.018477', 'article-title': 'Troponin and other biomarker levels and outcomes among patients ' 'hospitalized with COVID‐19: derivation and validation of the HA2T2 ' 'COVID‐19 mortality risk score', 'volume': '10', 'author': 'Manocha', 'year': '2021', 'journal-title': 'J Am Heart Assoc'}, { 'issue': '12', 'key': '10.1016/j.jiph.2021.10.024_bib0260', 'doi-asserted-by': 'crossref', 'first-page': '678', 'DOI': '10.3390/medicina56120678', 'article-title': 'Update on COVID-19 myocarditis', 'volume': '56', 'author': 'Agdamag', 'year': '2020', 'journal-title': 'Medicina'}, { 'issue': '02', 'key': '10.1016/j.jiph.2021.10.024_bib0265', 'doi-asserted-by': 'crossref', 'first-page': '155', 'DOI': '10.1055/s-0040-1721403', 'article-title': 'Will remdesivir reshape cardiovascular practice in COVID 19 era?', 'volume': '30', 'author': 'Idhrees', 'year': '2021', 'journal-title': 'Int J Angiol'}, { 'issue': '7', 'key': '10.1016/j.jiph.2021.10.024_bib0270', 'doi-asserted-by': 'crossref', 'first-page': '611', 'DOI': '10.3390/ph14070611', 'article-title': 'Cardiac events potentially associated to remdesivir: an analysis from ' 'the european spontaneous adverse event reporting system', 'volume': '14', 'author': 'Rafaniello', 'year': '2021', 'journal-title': 'Pharmaceuticals'}, { 'issue': '1', 'key': '10.1016/j.jiph.2021.10.024_bib0275', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s12959-020-00236-9', 'article-title': 'Thrombotic events following tocilizumab therapy in critically ill ' 'COVID-19 patients: a Façade for prognostic markers', 'volume': '18', 'author': 'Atallah', 'year': '2020', 'journal-title': 'Thromb J'}, { 'issue': '3', 'key': '10.1016/j.jiph.2021.10.024_bib0280', 'first-page': '200', 'article-title': 'Characteristics, treatment, outcomes and cause of death of invasively ' 'ventilated patients with COVID-19 ARDS in Milan, Italy', 'volume': '22', 'author': 'Zangrillo', 'year': '2020', 'journal-title': 'Crit Care Resusc'}], 'container-title': 'Journal of Infection and Public Health', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1876034121003452?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1876034121003452?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 1, 9]], 'date-time': '2022-01-09T04:49:30Z', 'timestamp': 1641703770000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1876034121003452'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 1]]}, 'references-count': 56, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2022, 1]]}}, 'alternative-id': ['S1876034121003452'], 'URL': 'http://dx.doi.org/10.1016/j.jiph.2021.10.024', 'relation': {}, 'ISSN': ['1876-0341'], 'subject': [ 'Infectious Diseases', 'Public Health, Environmental and Occupational Health', 'General Medicine'], 'container-title-short': 'Journal of Infection and Public Health', 'published': {'date-parts': [[2022, 1]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Efficacy of the early treatment with tocilizumab-hydroxychloroquine and ' 'tocilizumab-remdesivir in severe COVID-19 Patients', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Journal of Infection and Public Health', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.jiph.2021.10.024', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin ' 'Abdulaziz University for Health Sciences.', 'name': 'copyright', 'label': 'Copyright'}]}